Investors have shied away from Moderna in recent times as demand for its one and only product -- the coronavirus vaccine -- declines. But that particular product could be the driving force behind ...
The CDC panel's vote comes after the FDA approved and authorized the new shots from Moderna and Pfizer on Monday, amid an increase in COVID hospitalizations and concern about the spread of several ...
Moderna’s updated Covid vaccine provokes a “strong immune response” against fast-spreading coronavirus variants “Pirola,” “Fornax” and “Eris,” the company said Wednesday, amid a ...
Sept. 6, 2023 -- Moderna says its upcoming COVID-19 vaccine should work against the BA.2.86 variant that has caused worry about a possible surge in cases. “The company said its shot generated an ...
Moderna announced Wednesday that its updated coronavirus vaccine has been proven to offer a "strong human immune response" to a COVID-19 variant the CDC says "may be more capable" of infecting ...
Moderna announced Wednesday that its updated COVID-19 vaccine is effective against emerging variants of the virus, including the Pirola variant. The XBB.1.5 variant, also referred to as Kraken, has ...
The C.D.C. has approved the next round of Covid shots. Here’s what we know about who should get them, as well as the flu and R.S.V. vaccines, and when. By Apoorva Mandavilli Most Americans have ...
Moderna says its updated coronavirus vaccine offers a “strong" response to a new COVID-19 variant that is being monitored by the CDC and WHO. News that the Biden administration is planning to ...
The Centers for Disease Control and Prevention on Tuesday recommended people 6 months and older receive an updated COVID vaccine to protect themselves against getting sick or hospitalized from the ...
Moderna has pledged never to enforce its coronavirus vaccine patents in selected low- and middle-income countries and is launching a new initiative to give external researchers access to its ...
Moderna said its experimental mRNA-based flu vaccine generated a stronger immune response against four strains of the virus than a currently available flu vaccine. The late-stage trial results ...
The Commission has authorised the Spikevax XBB.1.5-adapted COVID-19 vaccine, developed by Moderna. This is another important step in the fight against the disease. It is the third adaptation of this ...
